CAI
PFE icon

Capital Advisors Inc’s Pfizer PFE Stock Holding History

Capital Advisors Inc’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.6M Sell
1,770,761
-52,013
-3% -$1.36M 0.63% 61
2026
Q1 		$51.2M Buy
1,822,774
+182,048
+11% +$4.85M 0.82% 43
2025
Q4 		$40.9M Buy
1,640,726
+105,365
+7% +$2.66M 0.66% 62
2025
Q3 		$39.1M Buy
1,535,361
+140,934
+10% +$3.48M 0.65% 62
2025
Q2 		$33.8M Sell
1,394,427
-19,045
-1% -$444K 0.61% 66
2025
Q1 		$35.8M Buy
1,413,472
+17,032
+1% +$446K 0.71% 58
2024
Q4 		$37M Sell
1,396,440
-43,305
-3% -$1.17M 0.74% 54
2024
Q3 		$41.7M Buy
1,439,745
+48,314
+3% +$1.41M 0.83% 42
2024
Q2 		$38.9M Buy
1,391,431
+250,348
+22% +$6.89M 0.8% 50
2024
Q1 		$31.7M Buy
1,141,083
+1,120,487
+5,440% +$31.1M 0.68% 59
2023
Q4 		$593K Buy
20,596
+1,418
+7% +$42.9K 0.01% 191
2023
Q3 		$636K Sell
19,178
-883,527
-98% -$31.2M 0.02% 159
2023
Q2 		$33.1M Buy
902,705
+122,179
+16% +$4.76M 0.84% 49
2023
Q1 		$31.8M Buy
780,526
+178,144
+30% +$7.69M 0.86% 47
2022
Q4 		$30.9M Buy
602,382
+4,983
+0.8% +$239K 0.88% 43
2022
Q3 		$25.6M Buy
597,399
+16,013
+3% +$778K 0.79% 45
2022
Q2 		$30.5M Buy
581,386
+20,945
+4% +$1.07M 0.91% 41
2022
Q1 		$29M Buy
560,441
+19,060
+4% +$989K 0.8% 49
2021
Q4 		$32M Buy
541,381
+20,514
+4% +$1.02M 0.86% 45
2021
Q3 		$22.4M Sell
520,867
-694
-0.1% -$30.7K 0.67% 61
2021
Q2 		$20.4M Buy
521,561
+9,274
+2% +$361K 0.61% 69
2021
Q1 		$18.6M Buy
512,287
+15,052
+3% +$534K 0.61% 70
2020
Q4 		$18.3M Sell
497,235
-26,603
-5% -$976K 0.65% 65
2020
Q3 		$18.2M Buy
523,838
+7,451
+1% +$261K 0.74% 52
2020
Q2 		$18.8M Buy
516,387
+51,718
+11% +$1.76M 0.78% 51
2020
Q1 		$14.4M Buy
464,669
+37,683
+9% +$1.28M 0.78% 48
2019
Q4 		$15.9M Buy
426,986
+137,115
+47% +$4.88M 0.69% 55
2019
Q3 		$11.9M Hold
289,871
– – 0.59% 55
2019
Q2 		$11.9M Buy
289,871
+215,372
+289% +$8.55M 0.59% 55
2019
Q1 		$3M Sell
74,499
-214,755
-74% -$8.6M 0.32% 56
2018
Q4 		$12M Sell
289,254
-131,916
-31% -$5.48M 0.78% 33
2018
Q3 		$17.6M Sell
421,170
-12,599
-3% -$485K 1.05% 26
2018
Q2 		$14.9M Sell
433,769
-355
-0.1% -$12.1K 0.9% 28
2018
Q1 		$14.6M Sell
434,124
-22,800
-5% -$784K 0.88% 28
2017
Q4 		$15.7M Buy
456,924
+7,196
+2% +$245K 0.92% 24
2017
Q3 		$15.2M Sell
449,728
-17,144
-4% -$551K 0.93% 26
2017
Q2 		$14.9M Buy
466,872
+28,015
+6% +$883K 0.93% 25
2017
Q1 		$14.2M Buy
438,857
+39,680
+10% +$1.25M 0.93% 27
2016
Q4 		$12.3M Buy
399,177
+38,569
+11% +$1.18M 0.86% 31
2016
Q3 		$11.6M Buy
360,608
+19,572
+6% +$654K 1.73% 16
2016
Q2 		$11.4M Buy
341,036
+23,318
+7% +$744K 1.76% 12
2016
Q1 		$8.93M Buy
317,718
+296,698
+1,412% +$8.47M 1.46% 25
2015
Q4 		$644K Buy
21,020
+12,615
+150% +$397K 0.11% 84
2015
Q3 		$250K Sell
8,405
-595
-7% -$19.1K 0.05% 105
2015
Q2 		$286K Buy
9,000
+2,114
+31% +$68.9K 0.05% 97
2015
Q1 		$227K Sell
6,886
-345
-5% -$11K 0.03% 109
2014
Q4 		$214K Buy
+7,231
New +$207K 0.04% 109
2014
Q1 		– Sell
-190,215
Closed -$5.53M – 119
2013
Q4 		$5.53M Sell
190,215
-74,210
-28% -$2.16M 1.22% 39
2013
Q3 		$7.21M Buy
264,425
+34,211
+15% +$931K 1.73% 18
2013
Q2 		$6.12M Buy
+230,214
New +$6.36M 1.65% 21

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Capital Advisors Inc's PFE Position: Q2 2026 in Review

Capital Advisors Inc reduced its Pfizer (PFE) stake by 2.9% in Q2 2026, selling an estimated $1.36M and leaving 1,770,761 shares worth $42.6M. The position accounts for 0.63% of the portfolio, ranked #61.

Capital Advisors Inc first reported a position in PFE in Q2 2013 and has held it in 50 quarters since. The position peaked at $51.2M in Q1 2026. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Capital Advisors Inc held 1,770,761 shares of Pfizer worth $42.6M as of Q2 2026.
  • Capital Advisors Inc sold 52,013 Pfizer shares in Q2 2026, an estimated $1.36M.
  • Pfizer made up 0.63% of Capital Advisors Inc's portfolio in Q2 2026, its #61 holding.
  • Capital Advisors Inc first reported a position in Pfizer in Q2 2013 and has held it in 50 quarters since.
  • Capital Advisors Inc's Pfizer position peaked at $51.2M in Q1 2026.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Capital Advisors Inc's 13F filing for Q2 2026, filed 23 Jul 2026.